$FISV

Fiserv Posts Loss In Q3; Affirms 2026 Organic Revenue, Adj. EPS Outlook

Fiserv (FISV) reported a Q3 net loss of $5.94B, including a $6.45B goodwill impairment charge. Adjusted EPS was $1.75, down from $2.04 YoY. Revenue decreased 1% to $5.20B. The company affirmed its 2026 outlook for organic revenue and adjusted EPS, and plans a $500M share buyback. Shares rose 7.82% pre-market.

Original reporting
Published Nov 3, 2026, 12:42 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 5:20 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Fiserv Posts Loss In Q3; Affirms 2026 Organic Revenue, Adj. EPS Outlook — source image
Decision brief

The 30-second read

$FISVBullishMed
01

Why it matters

The impairment likely drives near-term GAAP earnings pressure, but the reaffirmed 2026 organic revenue and adjusted EPS outlook, plus increased Project Elevate savings and a planned Q4 buyback, can stabilize expectations for adjusted earnings power.

02

Market read

Traders get a fresh earnings-and-guidance datapoint with explicit 2026 ranges and capital return details, explaining the pre-market move.

03

What to watch

The article does not quantify cash flow impact or segment drivers behind the impairment, so traders may underweight balance-sheet risk until more detail emerges in the full earnings release/call.

Relevance 9/10Novelty 8/10Timing: pre-market today, after Q3 results and 2026 guidance reaffirmation

Background

Fiserv’s Q3 results include a large non-cash goodwill impairment, while management says second-half initiatives are on track and guidance is reaffirmed for 2026.

Company-level read

Ticker impact

$FISVBullishMedium confidence
Context

Fiserv reported a Q3 GAAP loss tied to a $6.45B non-cash goodwill impairment and reaffirmed 2026 organic revenue and EPS guidance.

Expected impact

Likely two-sided reaction, with impairment weighing on valuation while reaffirmed 2026 outlook and buyback support limit downside.

Evidence & confidence

The article discloses both a major GAAP impairment and specific reaffirmed 2026 organic revenue and adjusted EPS ranges, plus a $500M Q4 buyback and Project Elevate savings increase.

Market effects

Payment-technology peers may see read-across on how impairment charges and cost-savings programs affect confidence in 2026 earnings durability.

US large-cap financial technology sentiment may remain choppy as investors weigh impairment-driven GAAP volatility versus adjusted guidance.

Limited direct global spillover beyond investor sentiment for US payments infrastructure providers.

Counterpoint

Investors may treat the goodwill impairment as non-cash and focus on the reaffirmed 2026 organic revenue and adjusted EPS range, potentially supporting a rebound in the stock.

Key entities

  • Fiserv, Inc.

    Reported Q3 net loss with a $6.45B non-cash goodwill impairment, reaffirmed 2026 organic revenue and adjusted EPS guidance, and increased Project Elevate savings to $1B.

Related articles

$FISVMed

What Fiserv (FISV) Said on Its Q3 Earnings Call

Fiserv (FISV) reported Q3 earnings, with Financial Solutions organic revenue up 2% and Merchant Solutions down 2%. The company expects Q4 growth in both segments. Project Elevate savings target was raised to $1B. Fiserv plans to restart share repurchases with $500M in Q4. Management highlighted AI initiatives and potential non-core business divestitures.

$FISVMedAI 8/10

Fiserv Beats Wall Street, But a Troubling Question Remains

Fiserv (FISV) reported Q3 adjusted earnings of $1.75 per share, beating estimates by $0.04, with adjusted revenue of $4.85 billion, exceeding expectations by $10 million. However, adjusted revenue declined 1% year-over-year, and margins fell to 31.2% from 37.0%. The company reaffirmed its 2026 outlook, with organic revenue growth expected to be flat and adjusted EPS between $7.20 and $7.40. Fiserv also announced plans to repurchase $500 million of stock in Q4, earlier than anticipated.

$FISVMed

Fiserv Stocks Jump 7.76% as Savings Target Doubles to $1 Billion

Fiserv (FISV) shares rose 7.76% to $55.96 after doubling its cost-cutting savings target to $1 billion and announcing $500 million in Q4 stock repurchases. Revenue fell 1% to $5.20 billion, while adjusted earnings were $1.75 per share. Management maintained annual adjusted earnings guidance at $7.20-$7.40. GuruFocus highlights 5 warning signs and a GF Score of 73/100, indicating mixed financial health.

$FISVMedAI 8/10

Fiserv Q3 2026 slides: stabilization theme drives 8% stock surge

Fiserv (FISV) reported Q3 2026 earnings, with adjusted EPS of $1.75 beating estimates and revenue matching expectations at $4.85B. Shares surged 8.42% on stabilization themes, including flat organic revenue growth and improved core banking metrics. The company doubled Project Elevate savings targets to $1B, aiming for long-term margin expansion. Fiserv also announced a $500M share buyback plan for Q4.